{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Phio Pharmaceuticals Corp."},"Symbol":{"label":"Symbol","value":"PHIO"},"Address":{"label":"Address","value":"257 SIMARANO DRIVE,SUITE 101, MARLBOROUGH, Massachusetts, 01752, United States"},"Phone":{"label":"Phone","value":"+1 508 767-3861"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.phiopharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James Cardia","title":"Vice President-Scientific Operations"},{"name":"Robert J. Bitterman","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}